Krystal Biotech

KRYSNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$9.882 B

$333.85 -0.84%

Close of 21 Sept 2026

Revenue

$389.1M

#2032 by revenue

Earnings

$204.8M

#997 by earnings

Shares outstanding

29,598,836

Latest filing cover page

P/E ratio

48.2

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#11Bio-TechneTECH$11.4B
#12Twist BioscienceTWST$11.0B
#13Krystal BiotechKRYS$9.88B
#14Kymera TherapeuticsKYMR$9.78B
#15QiagenQGEN$9.23B

What if Krystal Biotech were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,022,812

Per share 3,064× higher

Bitcoin $1.72T

$58,103.76

Per share 174× higher

Nvidia $5.48T

$185,137.62

Per share 555× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Krystal Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.